Innovent Biologics
1801.HK
#1224
Rank
C$25.84 B
Marketcap
C$14.82
Share price
-5.09%
Change (1 day)
-8.38%
Change (1 year)

Innovent Biologics (1801.HK) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$4.40 Billion

According to Innovent Biologics's latest financial reports the company's total liabilities are C$4.40 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Innovent Biologics - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$3.52 B111.1%
2024-12-31C$1.66 B9.77%
2023-12-31C$1.51 B12.62%
2022-12-31C$1.34 B14.1%
2021-12-31C$1.18 B98.01%
2020-12-31C$0.59 B29.11%
2019-12-31C$0.46 B21.76%
2018-12-31C$0.37 B-51.81%
2017-12-31C$0.78 B7.93%
2016-12-31C$0.73 B